Design, synthesis and biological activity of 5-fluorouracil-distamycin hybrids

Medicinal Chemistry Research

Volumn 10, Issue 6, 2001, Pages 390-403

  Baraldi, P G ^a   Romagnoli, R ^a   Martinez, A ^a   Pineda de las Infantas, M J ^a   Gallo, M A ^a   Espinosa, A ^a   Rutigliano, C ^a   Bianchi, N ^a   Gambari, R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 [1 METHYL 4 [1 METHYL 4 [N1 [5 FLUORO 2,4(1H,3H) PYRIMIDINEDIONE]PROPANOYLAMINO]PYRROLE 2 CARBOXAMIDO]PYRROLE 2 CARBOXAMIDO]PYRROLE 2 CARBOXAMIDO]PROPIONAMIDINE; ANTIBIOTIC AGENT; ANTIMETABOLITE; DISTAMYCIN A DERIVATIVE; FLUOROURACIL DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG DNA BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION;

EID: 0034892229     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Biospecific interaction analysis (BIA) of low-molecular weight DNA-binding drugs